Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eisai
Eisai
Epizyme snags $206M epigenetics deal with Eisai
Fierce Biotech
Thu, 03/10/11 - 12:03 pm
Eisai
Epizyme
epigenetics
Eisai to shave 900 from payroll over five years
Fierce Pharma
Thu, 03/3/11 - 12:12 pm
layoffs
Eisai
Eisai Forecasts Flat Sales Through 2016 After Patent Loss
Bloomberg
Thu, 03/3/11 - 07:58 am
Eisai
earnings
guidance
Eisai to team up with Sanofi on flu vaccine -Nikkei
Reuters
Wed, 03/2/11 - 10:36 am
vaccines
Flu
Eisai
Sanofi
Eisai Wins Japan Court’s Support for Aricept Patent Extension
Bloomberg
Wed, 02/23/11 - 07:48 am
Eisai
Aricept
Japan
Ranbaxy Got 30% Market Share for Generic Aricept in December
Bloomberg
Tue, 02/22/11 - 09:18 am
Ranbaxy
generics
Aricept
Eisai
Alzheimer's disease
Eisai’s 9-Month Profit Jumps 25% on Higher Drug Sales
Bloomberg
Tue, 02/1/11 - 07:14 am
earnings
Eisai
H3 Biomedicine Launches To Discover And Develop Next Generation Cancer Treatments
Medical News Today
Sun, 01/30/11 - 12:04 pm
H3 Biomedicine
Eisai
cancer
personalized medicine
Eisai’s Severe Sepsis Drug Fails in Final-Stage Study
Bloomberg
Tue, 01/25/11 - 11:04 am
Eisai
sepsis
eritoran
The FDA approvals of 2010
Fierce Biotech
Wed, 01/12/11 - 07:25 pm
Watson Pharmaceuticals
Theratechnologies
Shire
Savient
Sanofi
Roche
Orphan Europe
Novo Nordisk
Novartis
Merz
JNJ
HRA Pharma
Genzyme
Forest Labs
FDA
Eisai
Dainippon Sumitomo
Chemiche Fabrik Kresussler
Boehringer Ingelheim
Bayer
Auxilium
Amgen
Allergan
Acorda Therapeutics
Kanagawa Sponge Leads to Breast-Cancer Drug
WSJ Online
Tue, 01/4/11 - 09:32 pm
Eisai
breast cancer
Kanagawa sponge
Ranbaxy Gains Most in 8 Weeks on Report It Will Release Aricept Copy Today
Bloomberg
Mon, 11/29/10 - 09:09 am
Ranbaxy
generics
Aricept
Alzheimer's disease
Eisai
Ranbaxy to launch low-cost Alzheimer drug in US soon
Economic Times, India
Sun, 11/28/10 - 11:43 am
Ranbaxy
Aricept
Eisai
Pfizer
Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Bloomberg
Tue, 11/16/10 - 11:57 am
Eisai
Aricept
breast cancer
Eribulin
Eisai Wins U.S. Approval to Sell Drug Injected for Advanced Breast Cancer
Bloomberg
Mon, 11/15/10 - 06:26 pm
Eisai
breast cancer
FDA
Eribulin
Long Odds Seen For Diet Drugs
WSJ Online
Tue, 10/26/10 - 12:37 pm
obesity
Arena Pharmaceuticals
Eisai
Orexigen
Contrave
Court Says Teva Can Challenge Eisai Patents, Hurting Indian Rival Ranbaxy
Bloomberg
Wed, 10/6/10 - 06:52 pm
Teva Pharmaceuticals
India
Eisai
patents
Ranbaxy
Ranbaxy Has Sole Approval to Sell Generic Aricept in U.S., Regulator Says
Bloomberg
Tue, 09/21/10 - 11:59 am
Ranbaxy
Aricept
generics
Eisai
Alzheimer's disease
No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business
Seeking Alpha
Mon, 09/20/10 - 10:58 am
blood thinners
AstraZeneca
Bristol-Myers Squibb
Bayer
Eisai
Pfizer
Sanofi
Brilinta
Portola Pharmaceuticals
Boehringer Ingelheim
Eisai's Anti-Clotting Drug May Cut Heart Risks Without Increased Bleeding
Bloomberg
Mon, 08/30/10 - 11:21 am
Eisai
anti-clotting
Pages
« first
‹ previous
…
13
14
15
16
17
18
19
20
21
next ›
last »